Cytimm Therapeutics
- Biotech or pharma, therapeutic R&D
Clinical stage company aimed at developing best-in-class IL-2 based therapy for the treatments of cancer, autoimmune diseases, and neurodegenerative diseases. Our assets were developed with proprietary mRNA technology and protein-engineering technologies.